Repligen | RGEN - Stock


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Repligen

Repligen reported $244.7M in Stock for its fiscal quarter ending in March of 2023.


Stock Change
Agilent A:US USD 1.1B 8M
Bio Techne TECH:US USD 169.46M 9.23M
Catalent CTLT:US USD 841M 88M
Charles River Laboratories CRL:US USD 262.58M 6.78M
Danaher DHR:US USD 3.38B 273M
Exact Sciences EXAS:US USD 124.09M 5.83M
General Electric GE:US USD 16.2B 1.2B
Illumina ILMN:US USD 586M 18M
Myriad Genetics MYGN:US USD 21.8M 1.7M
NanoString Technologies NSTG:US USD 46.71M 3.44M
OraSure Technologies OSUR:US USD 77.19M 19.04M
Pacific Biosciences Of California PACB:US USD 61.96M 11.57M
Patterson Companies PDCO:US USD 939.1M 61.66M
Peregrine Pharmaceuticals PPHM:US USD 45.1M 6.04M
PerkinElmer PKI:US USD 429.42M 23.96M
Repligen RGEN:US USD 244.7M 6.43M
Thermo Fisher Scientific TMO:US USD 5.66B 30M
Waters WAT:US USD 499.42M 43.71M
West Pharmaceutical Services WST:US USD 447M 32.2M